Prelude approved to receive state grant funds early

WILMINGTON — With many therapies now in the clinical study phase, Prelude Therapeutics has received state approval to receive $2.6 million from previous grant awards early to aid the companies’ expansion efforts. The early release of state dollars comes at a time when the company continues to grow in its new headquarters and as its

Already a subscriber? Log in

To continue reading this article ...

Subscribe to Delaware Business Times right now and get access to subscriber-only content like this article. Plus get 24 issues of DBT via print or digital, special bonus issues, and discounted registration for our in-person events.

– Digital Partners -